NASDAQ:LVTX
Lava Therapeutics
- Stock
Last Close
1.66
25/09 13:46
Market Cap
50.22M
Beta: −0.50
Volume Today
2.64K
Avg: 70.82K
PE Ratio
−0.89
PFCF: 7.59
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | -21.53M - | -21.53M 0% | ||||
average payables | 678.38K - | 1.74M 157.06% | 3.26M 86.88% | 4.21M 29.04% | ||
average receivables | 849.82K - | 1.11M 30.24% | 1.99M 80.16% | 2.48M 24.20% | ||
book value per share | 0.32 - | 0.30 5.12% | 5.99 1,889.44% | 3.32 44.60% | 1.91 42.32% | |
capex per share | -0.04 - | -0.02 48.77% | -0.04 82.39% | -0.02 41.44% | -0.03 20.60% | |
capex to depreciation | -2.94 - | -1.09 63.05% | -1.37 25.95% | -0.75 45.11% | -0.57 24.00% | |
capex to operating cash flow | 0.09 - | 0.05 41.62% | 0.03 48.35% | -0.15 644.40% | 0.02 112.90% | |
capex to revenue | -0.14 - | -0.15 11.40% | -0.03 80.19% | -0.11 256.25% | ||
cash per share | 0.40 - | 0.62 56.82% | 8.88 1,321.68% | 5.13 42.31% | 3.58 30.25% | |
days of inventory on hand | ||||||
days payables outstanding | 466.05 - | |||||
days sales outstanding | 137.82 - | 53.58 61.12% | 61.25 14.31% | 91.61 49.57% | ||
debt to assets | 0.20 - | 0.20 0.69% | 0.04 81.52% | 0.04 3.22% | 0.06 63.34% | |
debt to equity | 0.30 - | 0.54 77.31% | 0.04 91.91% | 0.06 46.27% | 0.12 94.74% | |
dividend yield | ||||||
earnings yield | -0.04 - | -0.06 34.90% | -0.47 742.61% | -0.35 25.59% | -0.99 182.60% | |
enterprise value | 229.50M - | 286.14M 24.68% | -32.38M 111.32% | -4.15M 87.19% | 4.32M 204.11% | |
enterprise value over ebitda | -24.61 - | -18.77 23.75% | 0.73 103.89% | 0.12 83.15% | -0.11 190.54% | |
ev to operating cash flow | -26.64 - | -27.49 3.19% | 1.13 104.11% | -1.03 190.78% | -0.11 89.20% | |
ev to sales | 73.02 - | -6.48 108.87% | -0.21 96.70% | 0.64 398.24% | ||
free cash flow per share | -0.51 - | -0.43 15.21% | -1.49 244.75% | 0.13 108.96% | -1.49 1,214.04% | |
free cash flow yield | -0.04 - | -0.04 7.88% | -0.31 734.12% | 0.04 112.43% | -0.94 2,567.81% | |
graham net net | 0.25 - | 0.16 35.06% | 6.77 4,116.58% | 3.01 55.57% | 1.73 42.36% | |
graham number | 1.95 - | 2.11 8.54% | 17.59 732.37% | 9.59 45.49% | 8.22 14.22% | |
income quality | 0.89 - | 0.62 29.77% | 0.63 1.49% | -0.13 120.15% | 0.93 831.89% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | |
interest coverage | -111.43 - | -43.53 60.94% | -70.96 63.04% | -424.85 498.68% | -186.44 56.12% | |
interest debt per share | 0.10 - | 0.18 74.62% | 0.29 65.83% | 0.21 26.69% | 0.24 14.73% | |
inventory turnover | ||||||
invested capital | 0.30 - | 0.54 77.31% | 0.04 91.91% | 0.06 46.27% | 0.12 94.74% | |
market cap | 235.07M - | 297.90M 26.73% | 95.96M 67.79% | 90.73M 5.44% | 42.24M 53.45% | |
net current asset value | 4.67M - | 5.37M 15.01% | 115.63M 2,054.16% | 83.15M 28.09% | 48.37M 41.83% | |
net debt to ebitda | 0.60 - | 0.77 29.00% | 2.89 275.28% | 2.81 2.75% | 0.98 65.25% | |
net income per share | -0.53 - | -0.66 24.17% | -2.30 248.26% | -1.23 46.37% | -1.57 27.57% | |
operating cash flow per share | -0.47 - | -0.41 12.24% | -1.45 253.13% | 0.16 110.76% | -1.46 1,034.78% | |
payables turnover | 0.78 - | |||||
receivables turnover | 2.65 - | 6.81 157.21% | 5.96 12.52% | 3.98 33.14% | ||
research and ddevelopement to revenue | 4.28 - | 7.44 73.76% | 2.07 72.20% | 5.00 141.53% | ||
return on tangible assets | -1.11 - | -0.81 26.71% | -0.33 60.00% | -0.22 31.69% | -0.41 85.50% | |
revenue per share | 0.15 - | 0.25 63.72% | 0.75 195.58% | 0.25 66.15% | ||
roe | -1.67 - | -2.19 30.87% | -0.38 82.49% | -0.37 3.20% | -0.82 121.16% | |
roic | -1.19 - | -1.29 8.38% | -0.36 72.26% | -0.38 6.05% | -0.74 95.59% | |
sales general and administrative to revenue | 0.74 - | 2.43 230.56% | 0.73 70.05% | 1.88 158.11% | ||
shareholders equity per share | 0.32 - | 0.30 5.12% | 5.99 1,889.44% | 3.32 44.60% | 1.91 42.32% | |
stock based compensation to revenue | 0.15 - | 0.86 474.01% | 0.21 75.32% | 0.74 250.96% | ||
tangible asset value | 5.84M - | 7.63M 30.64% | 118.37M 1,450.46% | 86.04M 27.31% | 51.18M 40.52% | |
tangible book value per share | 0.32 - | 0.30 5.12% | 5.99 1,889.44% | 3.32 44.60% | 1.91 42.32% | |
working capital | 6.20M - | 11.07M 78.66% | 132.07M 1,093.12% | 118.58M 10.22% | 83.96M 29.20% |
All numbers in USD (except ratios and percentages)